Sales & Marketing News | pharmaphorum

News

As Trump visits UK, GSK pledges $30bn in US investment

GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.

News

Flood of warning letters follows DTC ad clampdown

The FDA has lost no time following through on its plan to tighten up DTC advertising of medicines, sending out dozens of untitled and warning letters.

News

Imfinzi becomes first NHS drug for aggressive lung cancer

AstraZeneca's PD-L1 inhibitor Imfinzi is the first drug therapy to be recommended for routine NHS use in limited-stage small cell lung cancer.

News

FDA's Makary explains 'overdue' pharma ads crackdown

FDA Commissioner Marty Makary has called DTC ads for medicines a "public health crisis" as the industry prepares for a regulatory crackdown.

News

RFK Jr expands ACIP ahead of highly anticipated meeting

Five members have been added to a controversial CDC vaccines panel ahead of a meeting this week that could have an impact on US immunisation policy.

News

Novo's oral GLP-1 is first to claim heart health label

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction.

As Trump visits UK, GSK pledges $30bn in US investment

Flood of warning letters follows DTC ad clampdown

Imfinzi becomes first NHS drug for aggressive lung cancer

FDA's Makary explains 'overdue' pharma ads crackdown

RFK Jr expands ACIP ahead of highly anticipated meeting

Novo's oral GLP-1 is first to claim heart health label

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks